GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion
In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
GSK announces FDA granted BTD for Jemperli
GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for ...
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission
In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
Yahoo Finance2 天
GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli
In another press release, GSK announced that the CHMP has recommended expanded use of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent ...
GSK的Jemperli获得CHMP对子宫内膜癌治疗的积极意见
在日本，GSK的呼吸道合胞病毒（RSV）疫苗Arexvy已获批用于50-59岁成年人。公司还报告了linerixibat的第三阶段GLISTEN试验的积极结果，该药物旨在治疗原发性胆汁性胆管炎患者的胆汁淤积性瘙痒。然而，由于预期2025年增长将趋于平缓，Jefferies和Guggenheim的金融分析师已下调了GSK的股票评级。
GSK's Cancer Drug Jemperli Nears EU Marketing Expansion -- 2nd Update
GSK's cancer drug Jemperli cleared an important hurdle ahead of potentially expanding its European Union marketing permission, in a boost to the pharmaceutical giant's oncology pipeline.
GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission — Update
GSK's cancer drug Jemperli cleared an important hurdle ahead of potentially receiving marketing permission from the European Medicines Agency.
Investing3 天
GSK's Jemperli receives positive CHMP opinion for endometrial cancer
Jemperli is a programmed death receptor-1 (PD-1)-blocking antibody and forms the backbone of GSK's immuno-oncology research and development program. The drug is currently being studied in various ...
Daily3 天
Jemperli bags USFDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal ...
London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for ...